Life Sciences

With the changing landscape of the global Life Sciences sector it is important that organizations are at the forefront of innovation. It is becoming an extremely competitive space where margins and operational agility are constantly being squeezed and tested which requires intelligent and strategic placement of R&D, distribution and business services hubs.

Regulations are tightening and competition for market share is clearly increasing identified by the very active M&A market over the last few years. At the core of this is the people and talent available across the sector.

Walter James partner with several clients including global public companies, VC backed SME’s, start-ups and family owned organisations to provide proactive and strategic human capital consultancy services.

Walter James work across:

  • Pharmaceuticals
  • Medical Devices
  • Biotechnology
  • Generics & Biosimilars
  • Consumer Health
  • Health & Nutrition
  • Animal Health
  • Diagnostics

With the recent acquisition of Euromedica, Walter James are now able to offer a true end to end vertically aligned expertise service to our clients in the Life Sciences sector with members of our leadership team having held VP level positions in FTSE 100 pharma organisations.

By combining this industry knowledge, unparalleled depth of research capability and internal process we can offer a best in class service and project completion rate with our clients.


Life science news

Nothing found.

Latest Insights

Introducing Fiona Motley

It is with great pleasure that we announce the appointment of Fiona Motley in the position of Client Services Director.

View More